Illuminar Consulting Pty Limited

Status: Registered
Australian Company Number: 134958259
Australian Business Number: 61134958259
Registration date: Fri, 16th Jan 2009
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Illuminar Consulting Pty Limited is a limited by shares Australian proprietary company. Located at NSW 2225 since 2016-02-24 the company is, as the updated on 2018-01-31 ABN database shows, registered. Known company numbers for Illuminar Consulting Pty Limited are as follows: ACN - 134958259, Australian Business Number - 61134958259. This company had suspended their activity from 2018-01-31 to 2018-01-31. This Australian proprietary company was previously located in NSW 2229 (from 2014-09-11 to 2016-02-24), NSW 2229 (from 2009-01-21 to 2014-09-11).

Details for ABN 61134958259

Type: Australian Private Company

ABN Status

Status From To
Cancelled Wed, 31st Jan 2018 current
Active Wed, 21st Jan 2009 Wed, 31st Jan 2018

Main Name

Name From To
Illuminar Consulting Pty Limited Wed, 21st Jan 2009 current

Main Location

Location From To
NSW 2225 Wed, 24th Feb 2016 current
NSW 2229 Thu, 11th Sep 2014 Wed, 24th Feb 2016
NSW 2229 Wed, 21st Jan 2009 Thu, 11th Sep 2014

Advertisements

Find company

NSW 2225 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.